Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02925312 · ClinicalTrials.gov registry record · NA
MedStar Health Type 2 Diabetes Pathway to Control
A NA study, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 419
- Enrollment target
NCT02925312 is a NA study that has completed, run by Medstar Health Research Institute. The registered enrollment target is 419 participants.
The verdict
NCT02925312, a NA study, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 419 participants
- Enrollment target
Study Summary
A Diabetes Institute (MDI), in partnership with key stakeholders-including Primary Care Providers- in a northeastern US regional, mixed-payer healthcare system), seeks to implement an evidence-based, technology-enabled, innovative, and integrated diabetes care management pathway (Boot Camp) for adult patients with uncontrolled type 2 diabetes (A1C\>/=9%) which will demonstrate improvement in diabetes clinical and health resources utilization outcomes.
Interventions
- OTHER Diabetes Pathway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 419 participants |
| Start Date | 2014-11 |
| Est. Completion | 2016-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02925312
The ClinicalTrials.gov registry entry for NCT02925312 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 419 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diabetes Pathway is the first listed.
NCT02925312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02925312 about?
NCT02925312 is a clinical study titled "MedStar Health Type 2 Diabetes Pathway to Control". A Diabetes Institute (MDI), in partnership with key stakeholders-including Primary Care Providers- in a northeastern US regional, mixed-payer healthcare system), seeks to implement an evidence-based, technology-enabled, innovative, and integrated diabetes care management pathway (Boot Camp) for adul...
What is the current status of trial NCT02925312?
This trial is currently completed. It is a NA study. The enrollment target is 419 participants. The study started on 2014-11. Estimated completion is 2016-12-31.
What interventions are being tested in trial NCT02925312?
The interventions under investigation include: Diabetes Pathway (OTHER).
Who is sponsoring clinical trial NCT02925312?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.